Clinical trial
Loading Dose or Standard Dose of Intravenous Ibandronate in Treating Patients…
NCT00492843 · Chinese Society of Lung Cancer, Other · Terminated
Key facts
| NCT number | NCT00492843 |
|---|---|
| Title | Loading Dose or Standard Dose of Intravenous Ibandronate in Treating Patients With Lung Cancer and Skeletal Metastasis |
| Official title | A Randomized Study to Evaluate the Safety and Efficacy of Loading Dose of Bondronat Versus Standard Dose of Bondronat in Patients With Lung Cancer and Skeletal Metastasis Experiencing Moderate to Severe Pain |
| Lead sponsor | Chinese Society of Lung Cancer, Other |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | Ibandronate (Bondronat) |
| Enrollment | 20 |
| Start date | Jul 1, 2007 |
| Primary completion | Jan 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Jun 27, 2007 |
| Last update posted | Feb 17, 2016 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: